表紙:医薬品無菌試験の世界市場:現状分析と予測(2022年~2028年)
市場調査レポート
商品コード
1145459

医薬品無菌試験の世界市場:現状分析と予測(2022年~2028年)

Pharmaceutical Sterility Testing Market: Current Analysis and Forecast (2022-2028)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 142 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
医薬品無菌試験の世界市場:現状分析と予測(2022年~2028年)
出版日: 2022年10月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 142 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品無菌試験の市場規模は、予測期間中に約9%という著しい速度で成長すると予想されています。市場の成長を後押しする主な要因には、人口の増加による効果的な医薬品への継続的な需要の高まり、疾患の有病率の上昇などが挙げられます。

当レポートでは、世界の医薬品無菌試験市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、サンプル別・タイプ別・地域別の分析、および企業プロファイルなどを提供しています。

目次

第1章 市場イントロダクション

  • 市場の定義
  • 主な目的
  • ステークホルダー
  • 制限

第2章 調査手法または前提条件

  • 医薬品無菌試験市場の調査プロセス
  • 医薬品無菌試験市場の調査手法
  • 回答者プロファイル

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19の影響

第6章 医薬品無菌試験市場の収益、2020年~2028年

第7章 市場洞察:サンプル別

  • 無菌薬
  • 医療機器
  • 生物製剤・治療薬

第8章 市場洞察:タイプ別

  • 機器
  • キット・試薬
  • サービス

第9章 市場洞察:地域別

  • 北米
    • 米国
    • カナダ
    • その他の北米
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • その他の地域

第10章 医薬品無菌試験の市場力学

  • 市場促進要因
  • 市場抑制要因
  • 影響分析

第11章 医薬品無菌試験市場の機会

第12章 医薬品無菌試験市場の動向

第13章 需要側と供給側の分析

  • 需要側の分析
  • 供給側の分析

第14章 バリューチェーン分析

第15章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第16章 企業プロファイル

  • Pacific Biolabs
  • STRERIS Corporation
  • Boston Analytical
  • Gibraltar Laboratories
  • Sartorius AG
  • SolviasAG
  • SGS AG
  • Toxikon Inc.
  • Merck KGaA
  • Charles River Laboratories International Inc.

第17章 免責事項

目次
Product Code: UMHE211229

The global pharmaceutical sterility testing market is expected to grow at a significant rate of around 9% during the forecast period. Sterilization may be defined as the statistically complete destruction of all microorganisms including the most resistant bacteria and spores. The continuously rising demand for effective medicines due to the increasing population and rising disease prevalence among them are important factors for the growth of pharmaceutical sterility testing. For instance, in 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Furthermore, strict government regulation on microbial control and good manufacturing process also contributes to the market growth of the pharmaceutical sterility testing industry.

Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, SolviasAG, SGS AG, Toxikon inc., Merck KGaA, and Charles River Laboratories International Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst sample, sterile drugs category to witness higher CAGR during the forecast period"

Based on the sample, the market has been categorized into sterile drugs, medical devices, and biologics & therapeutics. The sterile drugs category is expected to witness a higher CAGR during the forecast period. This is mainly due to these drugs directly coming in the contact with the internal body organs and the aftermath of the contaminated drugs can be severe. Furthermore, the rising demand for injectable drugs due to their high absorption in the body is also attributed to the segmental growth of sterile drugs.

"Amongst type, the services to hold a significant share in the market in 2020"

Based on the type, the market has been categorized into instruments, kits & reagents, and services. Among them, the service segment is expected to have significant growth in the market. The companies are also providing new services in the sterility testing market catalyzing the segmental growth in the market. For instance, in October 2019, Alcami Corporation launched a rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster-testing results to clients.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the pharmaceutical sterility testing industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. In 2020, North America held a significant share of the global pharmaceutical sterility testing market. This is mainly attributed to the high investment in the healthcare and pharmaceutical sectors coupled with the strict guidelines on the good manufacturing process. For instance, $192 million for coronavirus research and medical countermeasures from the government's Plan to Mobilize Science

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

Customization Options:

The global pharmaceutical sterility testing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Pharmaceutical Sterility Testing Market
  • 2.2. Research Methodology of the Pharmaceutical Sterility Testing Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL STERILITY TESTING MARKET

6 PHARMACEUTICAL STERILITY TESTING MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY SAMPLE

  • 7.1. Sterile Drugs
  • 7.2. Medical Devices
  • 7.3. Biologics & Therapeutics

8 MARKET INSIGHTS BY TYPE

  • 8.1. Instruments
  • 8.2. Kits & Reagents
  • 8.3. Services

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. The United States
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. The United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 PHARMACEUTICAL STERILITY TESTING MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 PHARMACEUTICAL STERILITY TESTING MARKET OPPORTUNITIES

12 PHARMACEUTICAL STERILITY TESTING MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Pacific Biolabs
  • 16.2. STRERIS Corporation
  • 16.3. Boston Analytical
  • 16.4. Gibraltar Laboratories
  • 16.5. Sartorius AG
  • 16.6. SolviasAG
  • 16.7. SGS AG
  • 16.8. Toxikon Inc.
  • 16.9. Merck KGaA
  • 16.10. Charles River Laboratories International Inc.

17 DISCLAIMER